CompanyGraph
What stands out
- Returns appear driven by leverage
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $5.56B, above the global median of $1.18B
- PositionOperating margin is 38%, higher than 95% of its Diagnostics & Research peers (median 6.3%)
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Returns appear driven by leverage
Financials view
Market Capitalization
5.56BUSDvs all stocks (USD)
Trailing P/E
34.18xvs Diagnostics & Research peers
Revenue (TTM)
1.22BUSDvs all stocks (USD)
Profit Margin
13.44%vs Diagnostics & Research peers
Beta
1.77xvs all stocks
52-Week Change
18.51%vs all stocks
Market Capitalization
5.56BUSDvs all stocks (USD)
Enterprise Value
7.49BUSDvs all stocks (USD)
Trailing P/E
34.18xvs Diagnostics & Research peers
Forward P/E
18.12xvs Diagnostics & Research peers
PEG Ratio
0.0641xvs Diagnostics & Research peers
Price to Sales (TTM)
4.57xvs Diagnostics & Research peers
Price to Book (MRQ)
8.35xvs Diagnostics & Research peers
Enterprise to Revenue
6.16xvs Diagnostics & Research peers
Enterprise to EBITDA
12.99xvs Diagnostics & Research peers
Gross Margin
55.38%vs Diagnostics & Research peers
Profit Margin
13.44%vs Diagnostics & Research peers
Operating Margin
37.96%vs Diagnostics & Research peers
Return on Assets (TTM)
8.60%vs Diagnostics & Research peers
Return on Equity (TTM)
27.78%vs Diagnostics & Research peers
Revenue (TTM)
1.22BUSDvs all stocks (USD)
Revenue per Share (TTM)
4.27USDUpdated Aug 28, 2026Quarterly Revenue Growth
9.20%vs Diagnostics & Research peers
Gross Profit (TTM)
668.51MUSDvs all stocks (USD)
EBITDA (TTM)
530.57MUSDvs all stocks (USD)
Net Income (TTM)
163.48MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
573.70%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
292.19MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
153.97MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Aug 28, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Diagnostics & Research peers
Revenue
1.16BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
518.08MUSDFY2025 · Dec 31, 2025Gross Profit
645.53MUSDFY2025 · Dec 31, 2025Operating Income
362.03MUSDvs all stocks (USD)
Pre-tax Income
147.51MUSDFY2025 · Dec 31, 2025Income Tax Expense
69.56MUSDFY2025 · Dec 31, 2025Net Income
77.95MUSDFY2025 · Dec 31, 2025EBIT
303.23MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
507.29MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
252.76MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
155.72MUSDFY2025 · Dec 31, 2025EPS (Basic)
0.2700USDFY2025 · Dec 31, 2025EPS (Diluted)
0.2700USDFY2025 · Dec 31, 2025Basic Shares Outstanding
283.96MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
283.96MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
77.95MUSDFY2025 · Dec 31, 2025Operating Cash Flow
276.60MUSDFY2025 · Dec 31, 2025Free Cash Flow
138.58MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
346.46MUSDFY2025 · Dec 31, 2025Income Tax Paid
60.87MUSDFY2025 · Dec 31, 2025Interest Paid
164.01MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
77.95MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
136.71MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
22.00KUSDFY2025 · Dec 31, 2025Stock-based Compensation
30.88MUSDFY2025 · Dec 31, 2025Other Non-cash Items
4.94MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
7.15MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
5.18MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
13.77MUSDFY2025 · Dec 31, 2025Capital Expenditures
-138.02MUSDFY2025 · Dec 31, 2025Other Investing Activity
2.87MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-135.14MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-86.10MUSDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-86.10MUSDFY2025 · Dec 31, 2025Other Financing Charges
-7.86MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-180.07MUSDFY2025 · Dec 31, 2025Shares Outstanding
285.36MSharesUpdated Aug 28, 2026Float Shares
185.23MSharesUpdated Aug 28, 2026Shares Short
12.12MSharesUpdated Aug 28, 2026Short Ratio
4.06daysvs all stocks
Short % of Shares Outstanding
4.90%vs all stocks
% Held by Insiders
2.20%vs all stocks
% Held by Institutions
107.06%vs all stocks
Total Cash (MRQ)
356.95MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
1.25USDUpdated Aug 28, 2026Total Debt (MRQ)
2.27BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
3.41xvs Diagnostics & Research peers
Current Ratio (MRQ)
2.80xvs Diagnostics & Research peers
Book Value per Share (MRQ)
2.33USDUpdated Aug 28, 2026Total Assets
3.26BUSDvs all stocks (USD)
Total Current Assets
613.41MUSDFY2025 · Dec 31, 2025Total Liabilities
2.66BUSDFY2025 · Dec 31, 2025Total Non-current Assets
2.65BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
2.41BUSDFY2025 · Dec 31, 2025Total Current Liabilities
249.58MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
344.62MUSDFY2025 · Dec 31, 2025Accounts Receivable
139.33MUSDFY2025 · Dec 31, 2025Inventory
54.38MUSDFY2025 · Dec 31, 2025Accounts Payable
77.96MUSDFY2025 · Dec 31, 2025Short-term Debt
23.19MUSDFY2025 · Dec 31, 2025Deferred Revenue
18.00MUSDFY2025 · Dec 31, 2025Other Current Liabilities
1.87MUSDFY2025 · Dec 31, 2025Long-term Debt
2.25BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
7.36MUSDFY2025 · Dec 31, 2025Common Stock (Book)
2.86MUSDFY2025 · Dec 31, 2025Retained Earnings
-532.09MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
606.03MUSDvs all stocks (USD)
Treasury Stock
17.01MUSDFY2025 · Dec 31, 202552-Week Low
13.09USDUpdated Aug 28, 202652-Week High
19.85USDUpdated Aug 28, 202652-Week Change
18.51%vs all stocks
Beta
1.77xvs all stocks
50-Day MA
17.93USDUpdated Aug 28, 2026200-Day MA
16.70USDUpdated Aug 28, 2026Avg 10-Day Volume
2.60MSharesUpdated Aug 28, 2026Avg 30-Day Volume
2.93MSharesUpdated Aug 28, 2026Diluted EPS (TTM)
0.5700USDUpdated Aug 28, 2026Other Income / Expense
-58.81MUSDFY2025 · Dec 31, 20253 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Elevated ROE With High Debt-to-Equity and Equity Multiplier
Return on equity reads high on a balance sheet carrying a lot of debt against that equity.
Reads
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
Where is this company structurally exposed?
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is 38%, higher than 95% of its Diagnostics & Research peers (median 6.3%)Significant
Operating margin: 0.38Industry median: 0.06Industry P95: 0.33Peers compared: 28.00
Return on equity is 27.8%, higher than 95% of its Diagnostics & Research peers (median 2.1%)Significant
Return on equity: 0.28Industry median: 0.02Industry P95: 0.22Peers compared: 28.00
Debt-to-equity is 3.41×, higher than 95% of its Diagnostics & Research peers (median 0.3×)Significant
Debt-to-equity: 3.41Industry median: 0.30Industry P95: 1.25Peers compared: 28.00
Structural Tensions
Returns appear driven by leverageSignificant
Return on Equity: 0.28Debt-to-Equity: 3.41
Financial Health
Altman Z-Score 1.82: grey zoneSignificant
Altman Z-Score: 1.82
High earnings qualityNotable
Earnings Quality Score: 1.15
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $5.56B, above the global median of $1.18BNotable
Market cap (USD): 5,559,101,006Global Median: 1,179,398,897.704
Revenue is $1.22B, above the global median of $534.05MNotable
Revenue (USD): 1,216,173,056Global Median: 534,052,387.958
Levered free cash flow is $153.97M, above the global median of $19.23MNotable
Levered free cash flow (USD): 153,967,120Global Median: 19,234,564.734
Companies that share the same coordination system — how they create, deliver, or capture value.
Inner Mongolia Junzheng Energy & Chemical Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Beijing Jingneng Power Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Acm Research Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Zhejiang Sanmei Chemical Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Archrock Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Inner Mongolia Mengdian Huarun Power Corporation Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Hengdian Group DMEGC Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Vallourec SA
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Cirrus Logic, Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Fortune Brands Innovations Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Radium Life Tech Co., Ltd.
3 interpretationsElevated ROE With High Debt-to-Equity and Equity MultiplierCash-Flow Ratios ElevatedElevated Leverage on Three Denominators
Resolute Holdings Management Inc.
3 interpretationsElevated ROE With High Debt-to-Equity and Equity MultiplierCash-Flow Ratios ElevatedElevated Leverage on Three Denominators
Shanghai Tianyong Engineering Co., Ltd.
3 interpretationsElevated ROE With High Debt-to-Equity and Equity MultiplierCash-Flow Ratios ElevatedElevated Leverage on Three Denominators